Navigation Links
Breast-Feeding May Not Protect Moms Against MS Relapse

By Ellin Holohan
HealthDay Reporter

WEDNESDAY, July 6 (HealthDay News) -- Hopes that breast-feeding can reduce flare-ups of multiple sclerosis have been dimmed by recent research in Italy.

Researchers at the University of Florence found no support for prior studies connecting breast-feeding with lower disease activity for women with the degenerative nerve disorder commonly known as MS.

Instead, they determined that women who were sicker tended not to breast-feed, leading to the conclusion that some breast-feeding mothers had fewer relapses simply because they were healthier.

"Breast-feeding should not be encouraged as a protective factor without an accurate evaluation of the specific patient characteristics," said Dr. Emilio Portaccio, lead author and neurologist in the university's department of neurology. "Our study is important due to a lack of a consensus on whether breast-feeding should be advised against in order to resume therapy soon after delivery."

Women with MS are cautioned not to take medications while breast-feeding. The findings suggest that nursing may not be possible for women "with high disease activity," said Portaccio. Those women should be counseled that MS drug treatment soon after delivery should be an option, the authors said.

Multiple sclerosis, a progressive autoimmune disorder characterized by deterioration in physical coordination, affects about 400,000 people in the United States. It strikes women twice as often as men, with symptoms varying greatly from one person to another, according to the National Multiple Sclerosis Society.

Typically, the disease goes into remission, sometimes for long periods of time, and flare-ups during pregnancy are rare, according to the society.

"The reason is not yet fully understood," said Portaccio.

But the effect of pregnancy on the course of the disease is "at best neutral," Portaccio said, noting that other autoimmune disease activity also declines while women are carrying children. During that time, an immune system "switch" changes from a "pro-inflammatory status to an anti-inflammatory status that promptly reverts after delivery." Symptoms then increase to an "even higher" level for a few months. Pregnancy is not believed to cause any long-term worsening of the disorder, however.

Several drugs are used to fight MS, which attacks myelin, the protective covering of nerve cells, causing inflammation. They are not considered safe for use during pregnancy, however.

For their study, the researchers looked at 298 women with full-term pregnancies from 2002 to 2008 at 21 MS treatment centers throughout Italy. Of those, about 34 percent breast-fed their babies for at least two months. The remaining mothers, who breast-fed for zero to two months, were labeled the non-breast-feeding group.

Follow-up lasted for a year. After adjusting for factors such as age and level of disability, the researchers found no significant difference in relapse rates between the breast-feeding and non-breast-feeding groups.

The only predictor of postpartum disease activity was the number of relapses before and during pregnancy, the researchers found.

The study, published online July 6 in Neurology, was conducted on behalf of the MS Study Group of the Italian Neurological Society.

The findings are "in line with what one might expect," said Dr. Fred Lublin, a neurologist at Mount Sinai Medical Center in New York City. "Healthier women tended to breast-feed."

The study "did not resolve the issue of breast-feeding," added Lublin, who is also director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai. "These studies are all observational and it's hard to draw a conclusion of cause and effect from an observational study." A controlled study is needed, he said.

One expert expressed concern about the study's methodology. Dr. Emmanuelle Waubant, a neurologist at the University of California San Francisco Multiple Sclerosis Center, said that grouping women who had breast-fed for less than two months with those who did not breast-feed at all could have affected the findings.

"Breast-feeding affects hormone production," which could affect disease activity, said Waubant, who is also an associate professor of neurology at the university.

But Lublin, who did not share that concern, said the researchers had used established criteria for group selection set by the World Health Organization.

More information

To learn more about pregnancy and multiple sclerosis, visit the National Multiple Sclerosis Society.

SOURCES: Emilio Portaccio, M.D., neurologist, University of Florence, Italy; Fred Lublin, M.D., neurologist and director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Medical Center, New York City; Emmanuelle Waubant, M.D., Ph.D., associate professor, neurology, and director, clinical research, University of California San Francisco Multiple Sclerosis Center; July 6, 2011, Neurology, online

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Breast-feeding May Shield Against Sudden Infant Death Syndrome
2. Breast-Feeding May Help Quell Behavior Problems
3. Breast-feeding May Influence Long-Term Health: Study
4. Longer Breast-Feeding May Be Key to Bigger Brains
5. Breast-Feeding May Cut Obesity Risk in Kids of Diabetic Moms
6. Breast-Feeding May Counter Some Effects of Childhood Cancer
7. Breast-Feeding Wont Rob Mom of Sleep: Study
8. Breast-Feeding Less Common for Black Moms
9. Antiretrovirals During Breast-Feeding Shield Babies From HIV, Study Shows
10. Wider Breast-Feeding Could Save Babies Lives
11. Long-Term Breast-Feeding Tied to More Aggressive Cancers
Post Your Comments:
Related Image:
 Breast-Feeding May Not Protect Moms Against MS Relapse
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology: